首页 > 最新文献

Population Health Metrics最新文献

英文 中文
Generating age-specific mortality statistics from incomplete death registration data: two applications of the empirical completeness method. 从不完全死亡登记数据生成年龄特异性死亡率统计:经验完备性方法的两种应用。
IF 3.3 2区 医学 Q2 Medicine Pub Date : 2021-06-07 DOI: 10.1186/s12963-021-00262-3
Tim Adair, Alan D Lopez

Background: The study aims to assess two approaches that apply the empirical completeness method to generate age-specific mortality statistics from incomplete death registration systems.

Methods: We use the empirical completeness method to calculate all-age death registration completeness, which is used with a model life table to generate mortality statistics and age-specific completeness using (1) the conventional method and (2) the equivalent deaths method. The results are compared with a capture-recapture (C-RC) study and three alternative mortality estimates for Brazilian states, and C-RC studies in Thailand, Oman and Vietnam, which independently estimate the level and age pattern of mortality or completeness.

Results: The empirical completeness method produces similar estimates of all-age completeness of registration to the C-RC studies. Compared with C-RC studies, at 15-59 years, the conventional method's estimates of mortality and completeness are more concordant, while at 60-84 years the equivalent death method's estimates are closer. Estimates of life expectancy from the two approaches each have similar concordance with the C-RC studies. For male adult mortality in Brazilian states, there is relatively strong average correlation of this study's estimates with three alternative estimates.

Conclusions: The two approaches produce mortality statistics from incomplete data that are mostly concordant with C-RC studies, and can be most usefully applied to subnational populations.

背景:本研究旨在评估两种应用经验完备性方法从不完全死亡登记系统中产生年龄特异性死亡率统计的方法。方法:采用经验完备性方法计算全年龄死亡登记完备性,并结合模型生命表采用(1)常规方法和(2)等效死亡方法生成死亡率统计数据和年龄特异性完备性。将结果与巴西各州的捕获-再捕获(C-RC)研究和三种替代死亡率估计,以及泰国、阿曼和越南的C-RC研究进行比较,后者独立估计死亡率水平和年龄模式或完整性。结果:经验完备性方法对C-RC研究的全年龄注册完备性产生了类似的估计。与C-RC研究相比,在15-59岁时,传统方法对死亡率和完整性的估计更为一致,而在60-84岁时,等效死亡方法的估计更接近。两种方法对预期寿命的估计都与C-RC研究有相似的一致性。对于巴西各州的男性成人死亡率,本研究的估计值与三种替代估计值之间存在相对较强的平均相关性。结论:这两种方法从不完整的数据中得出死亡率统计数据,这些数据大多与C-RC研究一致,并且可以最有效地应用于次国家人口。
{"title":"Generating age-specific mortality statistics from incomplete death registration data: two applications of the empirical completeness method.","authors":"Tim Adair,&nbsp;Alan D Lopez","doi":"10.1186/s12963-021-00262-3","DOIUrl":"https://doi.org/10.1186/s12963-021-00262-3","url":null,"abstract":"<p><strong>Background: </strong>The study aims to assess two approaches that apply the empirical completeness method to generate age-specific mortality statistics from incomplete death registration systems.</p><p><strong>Methods: </strong>We use the empirical completeness method to calculate all-age death registration completeness, which is used with a model life table to generate mortality statistics and age-specific completeness using (1) the conventional method and (2) the equivalent deaths method. The results are compared with a capture-recapture (C-RC) study and three alternative mortality estimates for Brazilian states, and C-RC studies in Thailand, Oman and Vietnam, which independently estimate the level and age pattern of mortality or completeness.</p><p><strong>Results: </strong>The empirical completeness method produces similar estimates of all-age completeness of registration to the C-RC studies. Compared with C-RC studies, at 15-59 years, the conventional method's estimates of mortality and completeness are more concordant, while at 60-84 years the equivalent death method's estimates are closer. Estimates of life expectancy from the two approaches each have similar concordance with the C-RC studies. For male adult mortality in Brazilian states, there is relatively strong average correlation of this study's estimates with three alternative estimates.</p><p><strong>Conclusions: </strong>The two approaches produce mortality statistics from incomplete data that are mostly concordant with C-RC studies, and can be most usefully applied to subnational populations.</p>","PeriodicalId":51476,"journal":{"name":"Population Health Metrics","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2021-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12963-021-00262-3","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39072026","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A Bayesian spatio-temporal analysis of mortality rates in Spain: application to the COVID-19 2020 outbreak. 西班牙死亡率贝叶斯时空分析:在2020年COVID-19疫情中的应用
IF 3.3 2区 医学 Q2 Medicine Pub Date : 2021-05-31 DOI: 10.1186/s12963-021-00259-y
Pedro Saavedra, Angelo Santana, Luis Bello, José-Miguel Pacheco, Esther Sanjuán

Background: The number of deaths attributable to COVID-19 in Spain has been highly controversial since it is problematic to tell apart deaths having COVID as the main cause from those provoked by the aggravation by the viral infection of other underlying health problems. In addition, overburdening of health system led to an increase in mortality due to the scarcity of adequate medical care, at the same time confinement measures could have contributed to the decrease in mortality from certain causes. Our aim is to compare the number of deaths observed in 2020 with the projection for the same period obtained from a sequence of previous years. Thus, this computed mortality excess could be considered as the real impact of the COVID-19 on the mortality rates.

Methods: The population was split into four age groups, namely: (< 50; 50-64; 65-74; 75 and over). For each one, a projection of the death numbers for the year 2020, based on the interval 2008-2020, was estimated using a Bayesian spatio-temporal model. In each one, spatial, sex, and year effects were included. In addition, a specific effect of the year 2020 was added ("outbreak"). Finally, the excess deaths in year 2020 were estimated as the count of observed deaths minus those projected.

Results: The projected death number for 2020 was 426,970 people, the actual count being 499,104; thus, the total excess of deaths was 72,134. However, this increase was very unequally distributed over the Spanish regions.

Conclusion: Bayesian spatio-temporal models have proved to be a useful tool for estimating the impact of COVID-19 on mortality in Spain in 2020, making it possible to assess how the disease has affected different age groups accounting for effects of sex, spatial variation between regions and time trend over the last few years.

背景:西班牙因COVID-19导致的死亡人数一直存在很大争议,因为很难将COVID作为主要原因的死亡与其他潜在健康问题的病毒感染加重引起的死亡区分开来。此外,由于缺乏适当的医疗保健,卫生系统负担过重导致死亡率增加,同时限制措施可能有助于减少某些原因造成的死亡率。我们的目的是将2020年观察到的死亡人数与从前几年序列中获得的同期预测进行比较。因此,这一计算出的死亡率超额可被视为COVID-19对死亡率的实际影响。方法:将人群分为4个年龄组,分别为:< 50;50 - 64;65 - 74;75岁及以上)。使用贝叶斯时空模型,根据2008-2020年的时间间隔,对每一种疾病2020年的死亡人数进行了预测。在每个模型中,都包含了空间、性别和年份的影响。此外,还增加了2020年的具体影响("疫情")。最后,以观察到的死亡人数减去预测的死亡人数来估计2020年的超额死亡人数。结果:2020年预计死亡人数为426970人,实际死亡人数为499104人;因此,死亡总人数为72 134人。然而,这一增长在西班牙各地区的分布非常不均匀。结论:贝叶斯时空模型已被证明是估计2019冠状病毒病对西班牙2020年死亡率影响的有用工具,可以评估疾病如何影响不同年龄组,并考虑到过去几年性别、区域间空间差异和时间趋势的影响。
{"title":"A Bayesian spatio-temporal analysis of mortality rates in Spain: application to the COVID-19 2020 outbreak.","authors":"Pedro Saavedra,&nbsp;Angelo Santana,&nbsp;Luis Bello,&nbsp;José-Miguel Pacheco,&nbsp;Esther Sanjuán","doi":"10.1186/s12963-021-00259-y","DOIUrl":"https://doi.org/10.1186/s12963-021-00259-y","url":null,"abstract":"<p><strong>Background: </strong>The number of deaths attributable to COVID-19 in Spain has been highly controversial since it is problematic to tell apart deaths having COVID as the main cause from those provoked by the aggravation by the viral infection of other underlying health problems. In addition, overburdening of health system led to an increase in mortality due to the scarcity of adequate medical care, at the same time confinement measures could have contributed to the decrease in mortality from certain causes. Our aim is to compare the number of deaths observed in 2020 with the projection for the same period obtained from a sequence of previous years. Thus, this computed mortality excess could be considered as the real impact of the COVID-19 on the mortality rates.</p><p><strong>Methods: </strong>The population was split into four age groups, namely: (< 50; 50-64; 65-74; 75 and over). For each one, a projection of the death numbers for the year 2020, based on the interval 2008-2020, was estimated using a Bayesian spatio-temporal model. In each one, spatial, sex, and year effects were included. In addition, a specific effect of the year 2020 was added (\"outbreak\"). Finally, the excess deaths in year 2020 were estimated as the count of observed deaths minus those projected.</p><p><strong>Results: </strong>The projected death number for 2020 was 426,970 people, the actual count being 499,104; thus, the total excess of deaths was 72,134. However, this increase was very unequally distributed over the Spanish regions.</p><p><strong>Conclusion: </strong>Bayesian spatio-temporal models have proved to be a useful tool for estimating the impact of COVID-19 on mortality in Spain in 2020, making it possible to assess how the disease has affected different age groups accounting for effects of sex, spatial variation between regions and time trend over the last few years.</p>","PeriodicalId":51476,"journal":{"name":"Population Health Metrics","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2021-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12963-021-00259-y","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39052871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Impact of 2017 ACC/AHA guideline on prevalence, awareness, treatment, control, and determinants of hypertension: a population-based cross-sectional study in southwest of Iran. 2017年ACC/AHA指南对高血压患病率、意识、治疗、控制和决定因素的影响:伊朗西南部一项基于人群的横断面研究
IF 3.3 2区 医学 Q2 Medicine Pub Date : 2021-05-25 DOI: 10.1186/s12963-021-00260-5
Fatemeh Sadeghi, Bahman Cheraghian, Zahra Mohammadi, Sadaf G Sepanlou, Sahar Masoudi, Zahra Rahimi, Leila Danehchin, Yousef Paridar, Farhad Abolnezhadian, Mohammad Noori, Seyed Ali Mard, Ali Akbar Shayesteh, Hossein Poustchi

Background: In 2017, the American College of Cardiology/American Heart Association (ACC/AHA) provided a new guideline for hypertension prevention and management. We aimed to update the prevalence, awareness, control, and determinants of hypertension based on this guideline in Khuzestan province, southwest of Iran, and to estimate the number of people who are eligible for non-pharmacologic and pharmacologic intervention.

Methods: This population-based cross-sectional study was conducted in Khuzestan, a large province in the southwest of Iran. Comprehensive information about the potential relating factors of hypertension was collected, blood pressure was measured, and anthropometric measurements were obtained. Moreover, the dietary pattern was evaluated in 2830 individuals, using a qualitative food frequency questionnaire.

Results: Among 30,506 participants, 30,424 individuals aged 20-65 years were eligible for the study. In comparison with the previous guideline released by the Joint National Committee (JNC8), the prevalence of hypertension in Khuzestan dramatically increased from 15.81 to 42.85% after implementation of the ACC/AHA guideline, which was more dominant in the male population and the 45-54 age group. The sex and age adjustment of the hypertension prevalence was estimated to be 39.40%. The percentage of hypertension awareness, treatment, and control were 45.85%, 35.42%, and 59.63%, which dropped to 22.72%, 26.37%, and 28.94% after implementation of new guideline, respectively.

Conclusions: In the ACC/AHA guideline, a higher number of individuals with the pre-hypertension condition were shifted into the hypertension category and the level of awareness, treatment, and control were dramatically decreased, which highlight a great need to expand the public health infrastructure for further managing the substantial increased burden on healthcare system. However, further studies with population over 65 years are required to estimate the eligibility for antihypertensive treatment in this province after implementation of new guideline.

背景:2017年,美国心脏病学会/美国心脏协会(ACC/AHA)为高血压预防和管理提供了新的指南。我们的目的是根据该指南更新伊朗西南部胡齐斯坦省高血压的患病率、意识、控制和决定因素,并估计有资格接受非药物和药物干预的人数。方法:这项基于人群的横断面研究是在伊朗西南部的一个大省胡齐斯坦进行的。收集高血压潜在相关因素的综合信息,测量血压,并进行人体测量。此外,采用定性食物频率问卷对2830人的饮食模式进行了评估。结果:在30,506名参与者中,30,424名年龄在20-65岁之间的人符合研究条件。与之前全国联合委员会(JNC8)发布的指南相比,ACC/AHA指南实施后,胡齐斯坦高血压患病率从15.81%急剧上升至42.85%,且在男性人群和45-54岁年龄组中更为明显。高血压患病率的性别和年龄调整估计为39.40%。高血压知晓率为45.85%、治疗率为35.42%、控制率为59.63%,新指南实施后分别降至22.72%、26.37%、28.94%。结论:在ACC/AHA指南中,有更多的高血压前期患者被转移到高血压类别,意识、治疗和控制水平急剧下降,这突出了扩大公共卫生基础设施以进一步管理医疗系统负担的必要性。然而,需要对65岁以上人群进行进一步研究,以评估新指南实施后该省抗高血压治疗的适格性。
{"title":"Impact of 2017 ACC/AHA guideline on prevalence, awareness, treatment, control, and determinants of hypertension: a population-based cross-sectional study in southwest of Iran.","authors":"Fatemeh Sadeghi,&nbsp;Bahman Cheraghian,&nbsp;Zahra Mohammadi,&nbsp;Sadaf G Sepanlou,&nbsp;Sahar Masoudi,&nbsp;Zahra Rahimi,&nbsp;Leila Danehchin,&nbsp;Yousef Paridar,&nbsp;Farhad Abolnezhadian,&nbsp;Mohammad Noori,&nbsp;Seyed Ali Mard,&nbsp;Ali Akbar Shayesteh,&nbsp;Hossein Poustchi","doi":"10.1186/s12963-021-00260-5","DOIUrl":"https://doi.org/10.1186/s12963-021-00260-5","url":null,"abstract":"<p><strong>Background: </strong>In 2017, the American College of Cardiology/American Heart Association (ACC/AHA) provided a new guideline for hypertension prevention and management. We aimed to update the prevalence, awareness, control, and determinants of hypertension based on this guideline in Khuzestan province, southwest of Iran, and to estimate the number of people who are eligible for non-pharmacologic and pharmacologic intervention.</p><p><strong>Methods: </strong>This population-based cross-sectional study was conducted in Khuzestan, a large province in the southwest of Iran. Comprehensive information about the potential relating factors of hypertension was collected, blood pressure was measured, and anthropometric measurements were obtained. Moreover, the dietary pattern was evaluated in 2830 individuals, using a qualitative food frequency questionnaire.</p><p><strong>Results: </strong>Among 30,506 participants, 30,424 individuals aged 20-65 years were eligible for the study. In comparison with the previous guideline released by the Joint National Committee (JNC8), the prevalence of hypertension in Khuzestan dramatically increased from 15.81 to 42.85% after implementation of the ACC/AHA guideline, which was more dominant in the male population and the 45-54 age group. The sex and age adjustment of the hypertension prevalence was estimated to be 39.40%. The percentage of hypertension awareness, treatment, and control were 45.85%, 35.42%, and 59.63%, which dropped to 22.72%, 26.37%, and 28.94% after implementation of new guideline, respectively.</p><p><strong>Conclusions: </strong>In the ACC/AHA guideline, a higher number of individuals with the pre-hypertension condition were shifted into the hypertension category and the level of awareness, treatment, and control were dramatically decreased, which highlight a great need to expand the public health infrastructure for further managing the substantial increased burden on healthcare system. However, further studies with population over 65 years are required to estimate the eligibility for antihypertensive treatment in this province after implementation of new guideline.</p>","PeriodicalId":51476,"journal":{"name":"Population Health Metrics","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2021-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12963-021-00260-5","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39017833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Estimating causes of out-of-hospital deaths in China: application of SmartVA methods. 估计中国院外死亡原因:SmartVA方法的应用
IF 3.3 2区 医学 Q2 Medicine Pub Date : 2021-05-04 DOI: 10.1186/s12963-021-00256-1
Jinlei Qi, Tim Adair, Hafizur R Chowdhury, Hang Li, Deirdre McLaughlin, Yunning Liu, Jiangmei Liu, Xinying Zeng, Jinling You, Sonja Firth, Renee Sorchik, Peng Yin, Lijun Wang, Maigeng Zhou, Alan D Lopez

Background: Most deaths in China occur at home, making it difficult to collect reliable cause of death (CoD) information. Verbal autopsy (VA) was applied using the SmartVA tool to a sample of home deaths in China to explore its feasibility as a means of improving the quality of CoD data.

Methods: The study was carried out in 22 districts in 9 provinces, located in north-east, central, and western areas of China during 2017 and 2018. Trained interviewers selected suitable respondents in each household to collect information using the Population Health Metrics Research Consortium (PHMRC) shortened and validated electronic VA questionnaire on tablets. The CoD was diagnosed from the interview data using the SmartVA-Analyze 2.0 software (Tariff 2.0).

Results: Non-communicable diseases (NCDs) dominated the leading causes of death in all age groups and for both sexes. After redistribution of undetermined causes, stroke (24%), ischemic heart diseases (IHD) (21%), chronic respiratory diseases (11%), and lung cancer (6%) were the leading causes of death. The cause fractions for level-one cause categories and ranking of specific causes were similar between SmartVA and results from the Global Burden of Disease (GBD) study.

Conclusion: Evidence from this large pilot study suggests that SmartVA is a feasible and plausible tool and could be a valuable tool to improve the quality and standardization of CoD information across China.

背景:中国的大多数死亡发生在家中,因此难以收集可靠的死因(CoD)信息。使用SmartVA工具将死因推断(VA)应用于中国的家庭死亡样本,以探讨其作为提高死因推断数据质量手段的可行性。方法:2017 - 2018年在东北、中部和西部9省22个区开展研究。训练有素的采访者在每个家庭中选择合适的受访者,使用人口健康计量研究联盟(PHMRC)缩短和有效的电子VA片剂问卷收集信息。使用SmartVA-Analyze 2.0软件(Tariff 2.0)对访谈数据进行CoD诊断。结果:非传染性疾病(NCDs)在所有年龄组和两性中都是主要死亡原因。在重新分配未确定的死因后,中风(24%)、缺血性心脏病(21%)、慢性呼吸系统疾病(11%)和肺癌(6%)是主要的死亡原因。在SmartVA和全球疾病负担(GBD)研究的结果之间,一级原因类别的原因分数和特定原因排名相似。结论:这项大型试点研究的证据表明,SmartVA是一种可行和可信的工具,可以成为提高中国CoD信息质量和标准化的有价值的工具。
{"title":"Estimating causes of out-of-hospital deaths in China: application of SmartVA methods.","authors":"Jinlei Qi,&nbsp;Tim Adair,&nbsp;Hafizur R Chowdhury,&nbsp;Hang Li,&nbsp;Deirdre McLaughlin,&nbsp;Yunning Liu,&nbsp;Jiangmei Liu,&nbsp;Xinying Zeng,&nbsp;Jinling You,&nbsp;Sonja Firth,&nbsp;Renee Sorchik,&nbsp;Peng Yin,&nbsp;Lijun Wang,&nbsp;Maigeng Zhou,&nbsp;Alan D Lopez","doi":"10.1186/s12963-021-00256-1","DOIUrl":"https://doi.org/10.1186/s12963-021-00256-1","url":null,"abstract":"<p><strong>Background: </strong>Most deaths in China occur at home, making it difficult to collect reliable cause of death (CoD) information. Verbal autopsy (VA) was applied using the SmartVA tool to a sample of home deaths in China to explore its feasibility as a means of improving the quality of CoD data.</p><p><strong>Methods: </strong>The study was carried out in 22 districts in 9 provinces, located in north-east, central, and western areas of China during 2017 and 2018. Trained interviewers selected suitable respondents in each household to collect information using the Population Health Metrics Research Consortium (PHMRC) shortened and validated electronic VA questionnaire on tablets. The CoD was diagnosed from the interview data using the SmartVA-Analyze 2.0 software (Tariff 2.0).</p><p><strong>Results: </strong>Non-communicable diseases (NCDs) dominated the leading causes of death in all age groups and for both sexes. After redistribution of undetermined causes, stroke (24%), ischemic heart diseases (IHD) (21%), chronic respiratory diseases (11%), and lung cancer (6%) were the leading causes of death. The cause fractions for level-one cause categories and ranking of specific causes were similar between SmartVA and results from the Global Burden of Disease (GBD) study.</p><p><strong>Conclusion: </strong>Evidence from this large pilot study suggests that SmartVA is a feasible and plausible tool and could be a valuable tool to improve the quality and standardization of CoD information across China.</p>","PeriodicalId":51476,"journal":{"name":"Population Health Metrics","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2021-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12963-021-00256-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38869056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Inequality of weight status in urban Cuba: 2001-2010. 古巴城市体重状况的不平等:2001-2010。
IF 3.3 2区 医学 Q2 Medicine Pub Date : 2021-05-04 DOI: 10.1186/s12963-021-00251-6
Peng Nie, Lanlin Ding, Alfonso Sousa-Poza, Alina Alfonso Leon, Hong Xue, Peng Jia, Liang Wang, Youfa Wang

Background: Although understanding changes in the body weight distribution and trends in obesity inequality plays a key role in assessing the causes and persistence of obesity, limited research on this topic is available for Cuba. This study thus analyzed changes in body mass index (BMI) and waist circumference (WC) distributions and obesity inequality over a 9-year period among urban Cuban adults.

Methods: Kolmogorov-Smirnov tests were first applied to the data from the 2001 and 2010 National Survey on Risk Factors and Chronic Diseases to identify a rightward shift in both the BMI and WC distributions over the 2001-2010 period. A Shapley technique decomposed the increase in obesity prevalence into a mean-growth effect and a (re)distributional component. A univariate assessment of obesity inequality was then derived by calculating both the Gini and generalized entropy (GE) measures. Lastly, a GE-based decomposition partitioned overall obesity inequality into within-group and between-group values.

Results: Despite some relatively pronounced left-skewing, both the BMI and WC distributions exhibited a clear rightward shift to which the increases in general and central obesity can be mostly attributed. According to the Gini coefficients, both general and central obesity inequality increased over the 2001-2010 period, from 0.105 [95% confidence interval (CI) = 0.103-0.106] to 0.110 [95% CI = 0.107-0.112] and from 0.083 [95% CI = 0.082-0.084] to 0.085 [95% CI = 0.084-0.087], respectively. The GE-based decomposition further revealed that both types of inequality were accounted for primarily by within-group inequality (93.3%/89.6% and 87.5%/84.8% in 2001/2010 for general/central obesity, respectively).

Conclusions: Obesity inequality in urban Cuba worsened over the 2001-2010 time period, with within-group inequality in overall obesity dominant over between-group inequality. In general, the results also imply that the rise in obesity inequality is immune to health care system characteristics.

背景:虽然了解体重分布的变化和肥胖不平等的趋势在评估肥胖的原因和持久性方面起着关键作用,但古巴对这一主题的研究有限。因此,本研究分析了古巴城市成年人9年来身体质量指数(BMI)和腰围(WC)分布的变化以及肥胖不平等。方法:首先将Kolmogorov-Smirnov检验应用于2001年和2010年全国危险因素和慢性疾病调查的数据,以确定2001-2010年期间BMI和WC分布的右移。Shapley技术将肥胖患病率的增加分解为平均增长效应和(重新)分布成分。然后通过计算基尼系数和广义熵(GE)度量得出肥胖不平等的单变量评估。最后,基于ge的分解将总体肥胖不平等划分为组内和组间值。结果:尽管有一些相对明显的左偏,但BMI和WC分布都表现出明显的右移,这是一般肥胖和中心性肥胖增加的主要原因。根据基尼系数,2001-2010年期间,一般肥胖不平等和中心肥胖不平等均有所增加,分别从0.105[95%可信区间(CI) = 0.103-0.106]增加到0.110 [95% CI = 0.107-0.112],从0.083 [95% CI = 0.082-0.084]增加到0.085 [95% CI = 0.084-0.087]。基于ge的分解进一步揭示,这两种不平等主要是由群体内不平等造成的(2001/2010年,普通肥胖和中心性肥胖的比例分别为93.3%/89.6%和87.5%/84.8%)。结论:2001-2010年期间,古巴城市肥胖不平等加剧,总体肥胖的组内不平等高于组间不平等。总的来说,研究结果还表明,肥胖不平等的加剧不受医疗保健系统特征的影响。
{"title":"Inequality of weight status in urban Cuba: 2001-2010.","authors":"Peng Nie,&nbsp;Lanlin Ding,&nbsp;Alfonso Sousa-Poza,&nbsp;Alina Alfonso Leon,&nbsp;Hong Xue,&nbsp;Peng Jia,&nbsp;Liang Wang,&nbsp;Youfa Wang","doi":"10.1186/s12963-021-00251-6","DOIUrl":"https://doi.org/10.1186/s12963-021-00251-6","url":null,"abstract":"<p><strong>Background: </strong>Although understanding changes in the body weight distribution and trends in obesity inequality plays a key role in assessing the causes and persistence of obesity, limited research on this topic is available for Cuba. This study thus analyzed changes in body mass index (BMI) and waist circumference (WC) distributions and obesity inequality over a 9-year period among urban Cuban adults.</p><p><strong>Methods: </strong>Kolmogorov-Smirnov tests were first applied to the data from the 2001 and 2010 National Survey on Risk Factors and Chronic Diseases to identify a rightward shift in both the BMI and WC distributions over the 2001-2010 period. A Shapley technique decomposed the increase in obesity prevalence into a mean-growth effect and a (re)distributional component. A univariate assessment of obesity inequality was then derived by calculating both the Gini and generalized entropy (GE) measures. Lastly, a GE-based decomposition partitioned overall obesity inequality into within-group and between-group values.</p><p><strong>Results: </strong>Despite some relatively pronounced left-skewing, both the BMI and WC distributions exhibited a clear rightward shift to which the increases in general and central obesity can be mostly attributed. According to the Gini coefficients, both general and central obesity inequality increased over the 2001-2010 period, from 0.105 [95% confidence interval (CI) = 0.103-0.106] to 0.110 [95% CI = 0.107-0.112] and from 0.083 [95% CI = 0.082-0.084] to 0.085 [95% CI = 0.084-0.087], respectively. The GE-based decomposition further revealed that both types of inequality were accounted for primarily by within-group inequality (93.3%/89.6% and 87.5%/84.8% in 2001/2010 for general/central obesity, respectively).</p><p><strong>Conclusions: </strong>Obesity inequality in urban Cuba worsened over the 2001-2010 time period, with within-group inequality in overall obesity dominant over between-group inequality. In general, the results also imply that the rise in obesity inequality is immune to health care system characteristics.</p>","PeriodicalId":51476,"journal":{"name":"Population Health Metrics","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2021-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12963-021-00251-6","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38949347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
The utility of self-rated health in population surveys: the role of bodyweight. 自评健康在人口调查中的效用:体重的作用。
IF 3.3 2区 医学 Q2 Medicine Pub Date : 2021-05-03 DOI: 10.1186/s12963-021-00255-2
Robert Bozick

Background: Self-rated health (SRH) is one of the most commonly used summary measures of overall health and well-being available to population scientists due to its ease of administration in large-scale surveys and to its efficacy in predicting mortality. This paper assesses the extent to which SRH is affected by its placement before or after questions about bodyweight on a survey, and whether differences in placement on the questionnaire affects SRH's predictive validity.

Methods: I assessed the validity of SRH in predicting the risk of mortality by comparing outcomes of sample members who were asked to rate their health before reporting on their bodyweight (the control group) and sample members who were asked to rate their health after reporting on their bodyweight (the treatment group). Both the control and treatment group were randomly assigned via an experiment administered as a module in a nationally representative sample of adults in the USA in 2019 (N = 2523).

Results: The odds of reporting a more favorable appraisal of health are 30% lower for sample members who were in the treatment group when compared with the control group. Additionally, the SRH of treatment group members is significantly associated with their risk of mortality, while the SRH of control group members is not.

Conclusion: The findings from this study suggest that for researchers to maximize the utility of SRH, closer attention needs to be paid to the context of the survey within which it asked. SRH is highly sensitive to the questions that precede it, and this sensitivity may in turn mischaracterize the true health of the population that the survey is intending to measure.

背景:自评健康(SRH)是人口科学家最常用的总体健康和福祉的综合衡量标准之一,因为它在大规模调查中易于管理,并且在预测死亡率方面有效。本文评估了在问卷调查中体重问题之前或之后放置SRH对SRH的影响程度,以及问卷放置的差异是否影响SRH的预测效度。方法:我通过比较在报告体重之前被要求评估健康状况的样本成员(对照组)和在报告体重之后被要求评估健康状况的样本成员(治疗组)的结果,来评估SRH预测死亡风险的有效性。对照组和治疗组都是通过2019年在美国全国代表性成人样本中作为一个模块进行的实验随机分配的(N = 2523)。结果:与对照组相比,治疗组的样本成员报告更有利的健康评估的几率降低了30%。此外,治疗组成员的SRH与其死亡风险显著相关,而对照组成员的SRH与死亡风险无显著相关。结论:本研究的结果表明,为了使SRH的效用最大化,研究人员需要更密切地关注调查的背景。性健康和生殖健康对其之前的问题高度敏感,而这种敏感性可能反过来错误地描述调查打算衡量的人口的真实健康状况。
{"title":"The utility of self-rated health in population surveys: the role of bodyweight.","authors":"Robert Bozick","doi":"10.1186/s12963-021-00255-2","DOIUrl":"https://doi.org/10.1186/s12963-021-00255-2","url":null,"abstract":"<p><strong>Background: </strong>Self-rated health (SRH) is one of the most commonly used summary measures of overall health and well-being available to population scientists due to its ease of administration in large-scale surveys and to its efficacy in predicting mortality. This paper assesses the extent to which SRH is affected by its placement before or after questions about bodyweight on a survey, and whether differences in placement on the questionnaire affects SRH's predictive validity.</p><p><strong>Methods: </strong>I assessed the validity of SRH in predicting the risk of mortality by comparing outcomes of sample members who were asked to rate their health before reporting on their bodyweight (the control group) and sample members who were asked to rate their health after reporting on their bodyweight (the treatment group). Both the control and treatment group were randomly assigned via an experiment administered as a module in a nationally representative sample of adults in the USA in 2019 (N = 2523).</p><p><strong>Results: </strong>The odds of reporting a more favorable appraisal of health are 30% lower for sample members who were in the treatment group when compared with the control group. Additionally, the SRH of treatment group members is significantly associated with their risk of mortality, while the SRH of control group members is not.</p><p><strong>Conclusion: </strong>The findings from this study suggest that for researchers to maximize the utility of SRH, closer attention needs to be paid to the context of the survey within which it asked. SRH is highly sensitive to the questions that precede it, and this sensitivity may in turn mischaracterize the true health of the population that the survey is intending to measure.</p>","PeriodicalId":51476,"journal":{"name":"Population Health Metrics","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2021-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12963-021-00255-2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38944178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Changes in liver-related mortality by etiology and sequelae: underlying versus multiple causes of death. 由病因和后遗症引起的肝脏相关死亡率的变化:潜在死亡与多种死亡原因
IF 3.3 2区 医学 Q2 Medicine Pub Date : 2021-04-29 DOI: 10.1186/s12963-021-00249-0
Ming-Jen Sheu, Fu-Wen Liang, Ching-Yih Lin, Tsung-Hsueh Lu

Background: The expanded definition of liver-related deaths includes a wide range of etiologies and sequelae. We compared the changes in liver-related mortality by etiology and sequelae for different age groups between 2008 and 2018 in the USA using both underlying and multiple cause of death (UCOD and MCOD) data.

Methods: We extracted mortality data from the CDC WONDER. Both the absolute (rate difference) and relative (rate ratio and 95% confidence intervals) changes were calculated to quantify the magnitude of change using the expanded definition of liver-related mortality.

Result: Using the expanded definition including secondary liver cancer and according to UCOD data, we identified 68,037 liver-related deaths among people aged 20 years and above in 2008 (29 per 100,000) and this increased to 90,635 in 2018 (33 per 100,000), a 13% increase from 2008 to 2018. However, according to MCOD data, the number of deaths was 113,219 (48 per 100,000) in 2008 and increased to 161,312 (58 per 100,000) in 2018, indicating a 20% increase. The increase according to MCOD was mainly due to increase in alcoholic liver disease and secondary liver cancer (liver metastasis) for each age group and hepatitis C virus (HCV) and primary liver cancer among decedents aged 65-74 years.

Conclusion: The direction of mortality change (increasing or decreasing) was similar in UCOD and MCOD data in most etiologies and sequelae, except secondary liver cancer. However, the extent of change differed between UCOD and MCOD data.

背景:肝脏相关死亡的扩展定义包括广泛的病因和后遗症。我们使用潜在和多原因死亡(UCOD和MCOD)数据,比较了2008年至2018年美国不同年龄组肝脏相关死亡率的病因和后遗症变化。方法:我们从CDC WONDER中提取死亡率数据。计算绝对(比率差)和相对(比率比和95%置信区间)变化,使用扩大的肝脏相关死亡率定义来量化变化的幅度。结果:使用包括继发性肝癌在内的扩展定义并根据UCOD数据,我们确定2008年20岁及以上人群中有68,037例肝脏相关死亡(每10万人中有29例),2018年这一数字增加到90,635例(每10万人中有33例),比2008年增加了13%。然而,根据MCOD的数据,2008年死亡人数为113219人(每10万人中有48人),2018年增加到161312人(每10万人中有58人),增长了20%。MCOD的增加主要是由于各年龄组酒精性肝病和继发性肝癌(肝转移)的增加以及65-74岁死者丙型肝炎病毒(HCV)和原发性肝癌的增加。结论:除继发性肝癌外,在大多数病因和后遗症中,UCOD和MCOD数据的死亡率变化方向(升高或降低)相似。然而,UCOD和MCOD数据之间的变化程度不同。
{"title":"Changes in liver-related mortality by etiology and sequelae: underlying versus multiple causes of death.","authors":"Ming-Jen Sheu,&nbsp;Fu-Wen Liang,&nbsp;Ching-Yih Lin,&nbsp;Tsung-Hsueh Lu","doi":"10.1186/s12963-021-00249-0","DOIUrl":"https://doi.org/10.1186/s12963-021-00249-0","url":null,"abstract":"<p><strong>Background: </strong>The expanded definition of liver-related deaths includes a wide range of etiologies and sequelae. We compared the changes in liver-related mortality by etiology and sequelae for different age groups between 2008 and 2018 in the USA using both underlying and multiple cause of death (UCOD and MCOD) data.</p><p><strong>Methods: </strong>We extracted mortality data from the CDC WONDER. Both the absolute (rate difference) and relative (rate ratio and 95% confidence intervals) changes were calculated to quantify the magnitude of change using the expanded definition of liver-related mortality.</p><p><strong>Result: </strong>Using the expanded definition including secondary liver cancer and according to UCOD data, we identified 68,037 liver-related deaths among people aged 20 years and above in 2008 (29 per 100,000) and this increased to 90,635 in 2018 (33 per 100,000), a 13% increase from 2008 to 2018. However, according to MCOD data, the number of deaths was 113,219 (48 per 100,000) in 2008 and increased to 161,312 (58 per 100,000) in 2018, indicating a 20% increase. The increase according to MCOD was mainly due to increase in alcoholic liver disease and secondary liver cancer (liver metastasis) for each age group and hepatitis C virus (HCV) and primary liver cancer among decedents aged 65-74 years.</p><p><strong>Conclusion: </strong>The direction of mortality change (increasing or decreasing) was similar in UCOD and MCOD data in most etiologies and sequelae, except secondary liver cancer. However, the extent of change differed between UCOD and MCOD data.</p>","PeriodicalId":51476,"journal":{"name":"Population Health Metrics","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2021-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12963-021-00249-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38932488","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
How do Japanese rate the severity of different diseases and injuries?-an assessment of disability weights for 231 health states by 37,318 Japanese respondents. 日本人如何评估不同疾病和伤害的严重程度?- 37,318名日本答复者对231个健康州的残疾权重进行评估。
IF 3.3 2区 医学 Q2 Medicine Pub Date : 2021-04-23 DOI: 10.1186/s12963-021-00253-4
Shuhei Nomura, Yoshiko Yamamoto, Daisuke Yoneoka, Juanita A Haagsma, Joshua A Salomon, Peter Ueda, Rintaro Mori, Damian Santomauro, Theo Vos, Kenji Shibuya

Background: Disability weights (DWs) are weight factors that reflect the severity of health states for estimates of disability-adjusted life years. A new set of global DWs was published for the Global Burden of Diseases and Injuries (GBD) 2013 study, which relied on sampling from various world regions, but included little data for countries in East Asia. This study aimed to measure DWs in Japan using comparable methods, and compare the results with previous estimates from the GBD 2013 DW study.

Methods: We conducted a web-based survey in 2019 to estimate DWs for 231 health states for the Japanese population. The survey included five new health states but otherwise followed the method of the GBD DW measurement study. The survey consisted of 15 paired comparison (PC) questions and 3 population health equivalence questions (PHE) per respondent. We analyzed PC data using probit regression and rescaled results to DW units between 0 (equivalent to full health) and 1 (equivalent to death).

Findings: We considered 37,318 nationally representative respondents. The values of the resulting DWs ranged from 0.707 (95% uncertainty interval (UI) 0.527-0.842) for spinal cord injury at neck level (untreated) to 0.004 (UI 0.001-0.009) for mild anemia. High correlation between Japanese DW and GBD 2013 DW was observed, but there was considerable disagreement. Out of 226 comparable health states, 55 (24.3%) showed more than a factor-of-two difference, of which 41 (74.6%) had a higher value in Japanese DW. Many of the health states with higher DW in the Japan study were injuries, including amputation and fracture, and hearing and vision loss, while mental, behavioral, and substance use disorders generally tended to be lower.

Conclusions: This study has created an empirical basis for assessment of Japanese DWs of health status. The findings from this study based on the Japanese population suggest that there might be contextual differences in rating the severity of health states compared to previous surveys conducted elsewhere.

背景:残疾权重(DWs)是反映健康状况严重程度的体重因子,用于估计残疾调整生命年。2013年全球疾病和伤害负担(GBD)研究公布了一套新的全球dw,该研究依赖于世界各区域的抽样,但东亚国家的数据很少。本研究旨在使用可比方法测量日本的DW,并将结果与GBD 2013 DW研究的先前估计结果进行比较。方法:我们在2019年进行了一项基于网络的调查,以估计日本人口231个健康状态的dw。该调查包括五种新的健康状态,但其他方面遵循GBD DW测量研究的方法。调查由15个配对比较(PC)问题和3个人口健康等效问题(PHE)组成。我们使用probit回归分析PC数据,并将结果重新调整为DW单位,介于0(相当于完全生命值)和1(相当于死亡)之间。研究结果:我们考虑了37,318名具有全国代表性的受访者。结果DWs的值从颈部脊髓损伤(未经治疗)的0.707(95%不确定区间(UI) 0.527-0.842)到轻度贫血的0.004 (UI 0.001-0.009)不等。日本DW与GBD 2013 DW有较高的相关性,但存在相当大的差异。在226个可比较的健康状态中,55个(24.3%)显示出超过两个因素的差异,其中41个(74.6%)在日本的DW值更高。在日本的研究中,许多DW较高的健康状况是受伤,包括截肢和骨折,听力和视力丧失,而精神、行为和物质使用障碍通常倾向于较低。结论:本研究为日本dw健康状况评估提供了实证基础。这项基于日本人口的研究结果表明,与之前在其他地方进行的调查相比,对健康状况严重程度的评级可能存在背景差异。
{"title":"How do Japanese rate the severity of different diseases and injuries?-an assessment of disability weights for 231 health states by 37,318 Japanese respondents.","authors":"Shuhei Nomura,&nbsp;Yoshiko Yamamoto,&nbsp;Daisuke Yoneoka,&nbsp;Juanita A Haagsma,&nbsp;Joshua A Salomon,&nbsp;Peter Ueda,&nbsp;Rintaro Mori,&nbsp;Damian Santomauro,&nbsp;Theo Vos,&nbsp;Kenji Shibuya","doi":"10.1186/s12963-021-00253-4","DOIUrl":"https://doi.org/10.1186/s12963-021-00253-4","url":null,"abstract":"<p><strong>Background: </strong>Disability weights (DWs) are weight factors that reflect the severity of health states for estimates of disability-adjusted life years. A new set of global DWs was published for the Global Burden of Diseases and Injuries (GBD) 2013 study, which relied on sampling from various world regions, but included little data for countries in East Asia. This study aimed to measure DWs in Japan using comparable methods, and compare the results with previous estimates from the GBD 2013 DW study.</p><p><strong>Methods: </strong>We conducted a web-based survey in 2019 to estimate DWs for 231 health states for the Japanese population. The survey included five new health states but otherwise followed the method of the GBD DW measurement study. The survey consisted of 15 paired comparison (PC) questions and 3 population health equivalence questions (PHE) per respondent. We analyzed PC data using probit regression and rescaled results to DW units between 0 (equivalent to full health) and 1 (equivalent to death).</p><p><strong>Findings: </strong>We considered 37,318 nationally representative respondents. The values of the resulting DWs ranged from 0.707 (95% uncertainty interval (UI) 0.527-0.842) for spinal cord injury at neck level (untreated) to 0.004 (UI 0.001-0.009) for mild anemia. High correlation between Japanese DW and GBD 2013 DW was observed, but there was considerable disagreement. Out of 226 comparable health states, 55 (24.3%) showed more than a factor-of-two difference, of which 41 (74.6%) had a higher value in Japanese DW. Many of the health states with higher DW in the Japan study were injuries, including amputation and fracture, and hearing and vision loss, while mental, behavioral, and substance use disorders generally tended to be lower.</p><p><strong>Conclusions: </strong>This study has created an empirical basis for assessment of Japanese DWs of health status. The findings from this study based on the Japanese population suggest that there might be contextual differences in rating the severity of health states compared to previous surveys conducted elsewhere.</p>","PeriodicalId":51476,"journal":{"name":"Population Health Metrics","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2021-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12963-021-00253-4","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38903431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Correction to: The cross-sectional average length of healthy life (HCAL): a measure that summarizes the history of cohort health and mortality. 修正:横断面平均健康寿命(HCAL):一种总结队列健康和死亡率历史的措施。
IF 3.3 2区 医学 Q2 Medicine Pub Date : 2021-04-21 DOI: 10.1186/s12963-021-00254-3
Markus Sauerberg, Michel Guillot, Marc Luy
{"title":"Correction to: The cross-sectional average length of healthy life (HCAL): a measure that summarizes the history of cohort health and mortality.","authors":"Markus Sauerberg,&nbsp;Michel Guillot,&nbsp;Marc Luy","doi":"10.1186/s12963-021-00254-3","DOIUrl":"https://doi.org/10.1186/s12963-021-00254-3","url":null,"abstract":"","PeriodicalId":51476,"journal":{"name":"Population Health Metrics","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2021-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12963-021-00254-3","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38902524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Public health implications of vaping in the USA: the smoking and vaping simulation model. 美国吸电子烟对公众健康的影响:吸烟和吸电子烟模拟模型。
IF 3.3 2区 医学 Q2 Medicine Pub Date : 2021-04-17 DOI: 10.1186/s12963-021-00250-7
David T Levy, Jamie Tam, Luz María Sanchez-Romero, Yameng Li, Zhe Yuan, Jihyoun Jeon, Rafael Meza

Background: Nicotine vaping products (NVPs) are increasingly popular worldwide. They may provide public health benefits if used as a substitute for smoking, but may create public health harms if used as a gateway to smoking or to discourage smoking cessation. This paper presents the Smoking and Vaping Model (SAVM), a user-friendly model which estimates the public health implications of NVPs in the USA.

Methods: SAVM adopts a cohort approach. We derive public health implications by comparing smoking- and NVP-attributable deaths and life-years lost under a No-NVP and an NVP Scenario. The No-NVP Scenario projects current, former, and never smoking rates via smoking initiation and cessation rates, with their respective mortality rates. The NVP Scenario allows for smoking- and NVP-specific mortality rates, switching from cigarette to NVP use, separate NVP and smoking initiation rates, and separate NVP and smoking cessation rates. After validating the model against recent US survey data, we present the base model with extensive sensitivity analyses.

Results: The SAVM projects that under current patterns of US NVP use and substitution, NVP use will translate into 1.8 million premature smoking- and vaping-attributable deaths avoided and 38.9 million life-years gained between 2013 and 2060. When the NVP relative risk is set to 5%, the results are sensitive to the level of switching and smoking cessation rates and to a lesser extent smoking initiation rates. When the NVP relative risk is raised to 40%, the public health gains in terms of averted deaths and LYL are reduced by 42% in the base case, and the results become much more sensitive to variations in the base case parameters.

Discussion: Policymakers, researchers, and other public health stakeholders can apply the SAVM to estimate the potential public health impact of NVPs in their country or region using their own data sources. In developing new simulation models involving NVPs, it will be important to conduct extensive sensitivity analysis and continually update and validate with new data.

Conclusion: The SAVM indicates the potential benefits of NVP use. However, given the uncertainty surrounding model parameters, extensive sensitivity analysis becomes particularly important.

背景:尼古丁电子烟产品(NVPs)在全球越来越受欢迎。如果将它们用作吸烟的替代品,可能会对公共健康有益,但如果将其用作吸烟或阻止戒烟的途径,可能会对公共健康造成危害。本文提出了吸烟和电子烟模型(SAVM),这是一个用户友好的模型,它估计了NVPs在美国的公共卫生影响。方法:SAVM采用队列研究方法。我们通过比较吸烟和非吸烟风险导致的死亡人数以及在无非吸烟风险和非吸烟风险情景下损失的生命年,得出公共卫生影响。No-NVP情景通过开始吸烟率和戒烟率及其各自的死亡率来预测当前吸烟率、戒烟率和从不吸烟率。NVP情景允许吸烟和NVP特异性死亡率,从卷烟转向使用NVP,单独的NVP和吸烟起始率,以及单独的NVP和戒烟率。在针对最近的美国调查数据验证模型后,我们提出了具有广泛敏感性分析的基本模型。结果:SAVM预测,在目前美国NVP的使用和替代模式下,NVP的使用将在2013年至2060年期间避免180万因吸烟和电子烟导致的过早死亡,并增加3890万生命年。当NVP相对风险设置为5%时,结果对转换率和戒烟率水平敏感,并且在较小程度上对吸烟开始率敏感。当NVP相对风险提高到40%时,在基本情况下,在避免死亡和生命周期方面的公共卫生收益减少了42%,并且结果对基本情况参数的变化变得更加敏感。讨论:政策制定者、研究人员和其他公共卫生利益攸关方可以利用各自的数据来源,将SAVM应用于估计本国或区域内非营利性项目的潜在公共卫生影响。在开发涉及NVPs的新模拟模型时,进行广泛的敏感性分析并不断更新和验证新数据将非常重要。结论:SAVM显示了使用NVP的潜在益处。然而,考虑到模型参数的不确定性,广泛的敏感性分析变得尤为重要。
{"title":"Public health implications of vaping in the USA: the smoking and vaping simulation model.","authors":"David T Levy,&nbsp;Jamie Tam,&nbsp;Luz María Sanchez-Romero,&nbsp;Yameng Li,&nbsp;Zhe Yuan,&nbsp;Jihyoun Jeon,&nbsp;Rafael Meza","doi":"10.1186/s12963-021-00250-7","DOIUrl":"https://doi.org/10.1186/s12963-021-00250-7","url":null,"abstract":"<p><strong>Background: </strong>Nicotine vaping products (NVPs) are increasingly popular worldwide. They may provide public health benefits if used as a substitute for smoking, but may create public health harms if used as a gateway to smoking or to discourage smoking cessation. This paper presents the Smoking and Vaping Model (SAVM), a user-friendly model which estimates the public health implications of NVPs in the USA.</p><p><strong>Methods: </strong>SAVM adopts a cohort approach. We derive public health implications by comparing smoking- and NVP-attributable deaths and life-years lost under a No-NVP and an NVP Scenario. The No-NVP Scenario projects current, former, and never smoking rates via smoking initiation and cessation rates, with their respective mortality rates. The NVP Scenario allows for smoking- and NVP-specific mortality rates, switching from cigarette to NVP use, separate NVP and smoking initiation rates, and separate NVP and smoking cessation rates. After validating the model against recent US survey data, we present the base model with extensive sensitivity analyses.</p><p><strong>Results: </strong>The SAVM projects that under current patterns of US NVP use and substitution, NVP use will translate into 1.8 million premature smoking- and vaping-attributable deaths avoided and 38.9 million life-years gained between 2013 and 2060. When the NVP relative risk is set to 5%, the results are sensitive to the level of switching and smoking cessation rates and to a lesser extent smoking initiation rates. When the NVP relative risk is raised to 40%, the public health gains in terms of averted deaths and LYL are reduced by 42% in the base case, and the results become much more sensitive to variations in the base case parameters.</p><p><strong>Discussion: </strong>Policymakers, researchers, and other public health stakeholders can apply the SAVM to estimate the potential public health impact of NVPs in their country or region using their own data sources. In developing new simulation models involving NVPs, it will be important to conduct extensive sensitivity analysis and continually update and validate with new data.</p><p><strong>Conclusion: </strong>The SAVM indicates the potential benefits of NVP use. However, given the uncertainty surrounding model parameters, extensive sensitivity analysis becomes particularly important.</p>","PeriodicalId":51476,"journal":{"name":"Population Health Metrics","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2021-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12963-021-00250-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38888686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 20
期刊
Population Health Metrics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1